Dr. Mark Tomishima, director of the SKI Stem Cell Research Facility in NYC, shares insights into the crucial role of stem cell core facilities in advancing research. He discusses groundbreaking projects like creating organoid kidney structures and the ethical considerations of stem cell therapy, including immune rejection challenges. The conversation also highlights exciting advancements such as gene editing technologies and the progress of placenta-derived stem cells. Get ready for a blend of science and humor that showcases the collaborative spirit in the stem cell research community!